BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 25211095)

  • 21. Epigenetic inactivation of the miR-34a in hematological malignancies.
    Chim CS; Wong KY; Qi Y; Loong F; Lam WL; Wong LG; Jin DY; Costello JF; Liang R
    Carcinogenesis; 2010 Apr; 31(4):745-50. PubMed ID: 20118199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-16 mediates the regulation of a senescence-apoptosis switch in cutaneous T-cell and other non-Hodgkin lymphomas.
    Kitadate A; Ikeda S; Teshima K; Ito M; Toyota I; Hasunuma N; Takahashi N; Miyagaki T; Sugaya M; Tagawa H
    Oncogene; 2016 Jul; 35(28):3692-704. PubMed ID: 26640145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myc represses miR-15a/miR-16-1 expression through recruitment of HDAC3 in mantle cell and other non-Hodgkin B-cell lymphomas.
    Zhang X; Chen X; Lin J; Lwin T; Wright G; Moscinski LC; Dalton WS; Seto E; Wright K; Sotomayor E; Tao J
    Oncogene; 2012 Jun; 31(24):3002-3008. PubMed ID: 22002311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA Expression Profile in Bone Marrow and Lymph Nodes in B-Cell Lymphomas.
    Veryaskina YA; Titov SE; Kovynev IB; Pospelova TI; Fyodorova SS; Shebunyaeva YY; Sumenkova DV; Zhimulev IF
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered expression of miRNAs and methylation of their promoters are correlated in neuroblastoma.
    Maugeri M; Barbagallo D; Barbagallo C; Banelli B; Di Mauro S; Purrello F; Magro G; Ragusa M; Di Pietro C; Romani M; Purrello M
    Oncotarget; 2016 Dec; 7(50):83330-83341. PubMed ID: 27829219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Tumor Suppressive mir-148a Is Epigenetically Inactivated in Classical Hodgkin Lymphoma.
    Paczkowska J; Janiszewska J; Bein J; Schneider M; Bednarek K; Ustaszewski A; Hartmann S; Hansmann ML; Giefing M
    Cells; 2020 Oct; 9(10):. PubMed ID: 33066457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic regulation and functional characterization of microRNA-142 in mesenchymal cells.
    Skårn M; Barøy T; Stratford EW; Myklebost O
    PLoS One; 2013; 8(11):e79231. PubMed ID: 24236112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel miRNA genes deregulated by aberrant methylation in ovarian carcinoma are involved in metastasis.
    Loginov VI; Pronina IV; Burdennyy AM; Filippova EA; Kazubskaya TP; Kushlinsky DN; Utkin DO; Khodyrev DS; Kushlinskii NE; Dmitriev AA; Braga EA
    Gene; 2018 Jul; 662():28-36. PubMed ID: 29631007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia--implications on constitutive activation of NFκB pathway.
    Wang LQ; Kwong YL; Kho CS; Wong KF; Wong KY; Ferracin M; Calin GA; Chim CS
    Mol Cancer; 2013 Dec; 12():173. PubMed ID: 24373626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mantle cell lymphoma: transcriptional regulation by microRNAs.
    Di Lisio L; Gómez-López G; Sánchez-Beato M; Gómez-Abad C; Rodríguez ME; Villuendas R; Ferreira BI; Carro A; Rico D; Mollejo M; Martínez MA; Menárguez J; Díaz-Alderete A; Gil J; Cigudosa JC; Pisano DG; Piris MA; Martínez N
    Leukemia; 2010 Jul; 24(7):1335-42. PubMed ID: 20485376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genome-wide methylation analyses identify a subset of mantle cell lymphoma with a high number of methylated CpGs and aggressive clinicopathological features.
    Enjuanes A; Albero R; Clot G; Navarro A; Beà S; Pinyol M; Martín-Subero JI; Klapper W; Staudt LM; Jaffe ES; Rimsza L; Braziel RM; Delabie J; Cook JR; Tubbs RR; Gascoyne R; Connors JM; Weisenburger DD; Greiner TC; Chan WC; López-Guillermo A; Rosenwald A; Ott G; Campo E; Jares P
    Int J Cancer; 2013 Dec; 133(12):2852-63. PubMed ID: 23754783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-150 inhibits proliferation of mantle-cell lymphoma cells via regulation of MET.
    Zhang WJ; Chen FF; Wang YQ; Yu W; Dong FL; Zhuang HX
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12063-12072. PubMed ID: 33336724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epigenetic silencing of the 3p22 tumor suppressor DLEC1 by promoter CpG methylation in non-Hodgkin and Hodgkin lymphomas.
    Wang Z; Li L; Su X; Gao Z; Srivastava G; Murray PG; Ambinder R; Tao Q
    J Transl Med; 2012 Oct; 10():209. PubMed ID: 23050586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA expression profiling and DNA methylation signature for deregulated microRNA in cutaneous T-cell lymphoma.
    Sandoval J; Díaz-Lagares A; Salgado R; Servitje O; Climent F; Ortiz-Romero PL; Pérez-Ferriols A; Garcia-Muret MP; Estrach T; Garcia M; Nonell L; Esteller M; Pujol RM; Espinet B; Gallardo F
    J Invest Dermatol; 2015 Apr; 135(4):1128-1137. PubMed ID: 25405321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Promoter hypomethylation mediated upregulation of MicroRNA-10b-3p targets FOXO3 to promote the progression of esophageal squamous cell carcinoma (ESCC).
    Lu YF; Yu JR; Yang Z; Zhu GX; Gao P; Wang H; Chen SY; Zhang J; Liu MY; Niu Y; Wei XM; Wang W; Ye FJ; Zhang LX; Zhao Y; Sun GG
    J Exp Clin Cancer Res; 2018 Dec; 37(1):301. PubMed ID: 30514328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-199a mediated the dissemination of human mantle cell lymphoma by interacting with the CCR7/CCL21 pair.
    Li W; Xue W; Wang X; Fu X; Sun Z; Li Z; Chang Y; Zhang X; Zhou Z; Chen C; Zhang M
    Anticancer Drugs; 2018 Oct; 29(9):861-870. PubMed ID: 29979193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor-specific methylation of the 8p22 tumor suppressor gene DLC1 is an epigenetic biomarker for Hodgkin, nasal NK/T-cell and other types of lymphomas.
    Ying J; Li H; Murray P; Gao Z; Chen YW; Wang Y; Lee KY; Chan AT; Ambinder RF; Srivastava G; Tao Q
    Epigenetics; 2007; 2(1):15-21. PubMed ID: 17965626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-18b overexpression identifies mantle cell lymphoma patients with poor outcome and improves the MIPI-B prognosticator.
    Husby S; Ralfkiaer U; Garde C; Zandi R; Ek S; Kolstad A; Jerkeman M; Laurell A; Räty R; Pedersen LB; Pedersen A; Ehinger M; Sundström C; Karjalainen-Lindsberg ML; Delabie J; Clasen-Linde E; Brown P; Cowland JB; Workman CT; Geisler CH; Grønbæk K
    Blood; 2015 Apr; 125(17):2669-77. PubMed ID: 25736311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. microRNA-199a-3p, DNMT3A, and aberrant DNA methylation in testicular cancer.
    Chen BF; Gu S; Suen YK; Li L; Chan WY
    Epigenetics; 2014 Jan; 9(1):119-28. PubMed ID: 23959088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Demethylation of miR-9-3 and miR-193a genes suppresses proliferation and promotes apoptosis in non-small cell lung cancer cell lines.
    Wang J; Yang B; Han L; Li X; Tao H; Zhang S; Hu Y
    Cell Physiol Biochem; 2013; 32(6):1707-19. PubMed ID: 24356455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.